August 18, 2017

Pemetrexed to be funded from 1st November 2017

Today PHARMAC announced the approval of a proposal to fund pemetrexed for the treatment of mesothelioma and non-small cell lung cancer (NSCLC). Says Philip Hope of Lung Foundation New Zealand; “We were pleased to be informed today that pemetrexed will be funded in the public health system from the 1st November 2017.” “Pemetrexed has improved […]